Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAT2 Genotyping in INH Titration for Anti-TB Medication-induced Hepatitis
NCT00728546Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2008
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid in Tuberculosis (TB), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00728546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728546.